CVE-2022-37461
CVE-2022-37461 is a medium-severity vulnerability in Canon Medical Vitrea View with a CVSS 3.x base score of 6.1. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-79.
Key facts
- Severity: Medium (CVSS 3.x base score 6.1)
- EPSS exploit prediction: 1% (56th percentile)
- Actively exploited: Not listed in CISA KEV
- Weakness: CWE-79
- Affected product: Canon Medical Vitrea View
- Published:
- Last modified:
Description
Multiple cross-site scripting (XSS) vulnerabilities in Canon Medical Vitrea View 7.x before 7.7.6 allow remote attackers to inject arbitrary web script or HTML via (1) the input after the error subdirectory to the /vitrea-view/error/ subdirectory, or the (2) groupID, (3) offset, or (4) limit parameter to an Administrative Panel (Group and Users) page. There is a risk of an attacker retrieving patient information.
Frequently asked questions
- What is CVE-2022-37461?
- Multiple cross-site scripting (XSS) vulnerabilities in Canon Medical Vitrea View 7.x before 7.7.6 allow remote attackers to inject arbitrary web script or HTML via (1) the input after the error subdirectory to the /vitrea-view/error/ subdirectory, or the (2) groupID, (3) offset, or (4) limit parameter to an Administrative Panel (Group and Users) page. There is a risk of an attacker retrieving patient information.
- How severe is CVE-2022-37461?
- CVE-2022-37461 has a CVSS 3.x base score of 6.1, rated medium severity. It is exploitable over network with low attack complexity, requires no privileges and user interaction. Impact on confidentiality is low, integrity low, and availability none.
- Is CVE-2022-37461 being actively exploited?
- It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (56th percentile), an estimate of the probability of exploitation in the next 30 days.
- What products are affected by CVE-2022-37461?
- CVE-2022-37461 affects Canon Medical Vitrea View. See the affected-products list for the exact vulnerable versions.
- How do I fix CVE-2022-37461?
- Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
- When was CVE-2022-37461 published?
- CVE-2022-37461 was published on 2022-09-30 and last updated on 2026-06-17.
References
- https://www.trustwave.com/en-us/resources/security-resources/security-advisories/?fid=30693
- https://www.vitalimages.com/customer-success-support-program/vital-images-software-security-updates/
- https://www.vitalimages.com/vitrea-vision/vitrea-view/
Affected products (1)
- cpe:2.3:a:canon:medical_vitrea_view:*:*:*:*:*:*:*:*
Other CWE-79 (Cross-site Scripting (XSS)) vulnerabilities
- CVE-2025-49410 — Critical (CVSS 10.0): Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in Imran Emu TC…
- CVE-2024-47875 — Critical (CVSS 10.0): DOMPurify is a DOM-only, super-fast, uber-tolerant XSS sanitizer for HTML, MathML and SVG. DOMpurify was vulnerable to…
- CVE-2024-6886 — Critical (CVSS 10.0): Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting') vulnerability in Gitea…
- CVE-2023-45144 — Critical (CVSS 10.0): com.xwiki.identity-oauth:identity-oauth-ui is a package to aid in building identity and service providers based on…
- CVE-2023-45138 — Critical (CVSS 10.0): Change Request is an pplication allowing users to request changes on a wiki without publishing the changes directly.…
- CVE-2022-4361 — Critical (CVSS 10.0): Keycloak, an open-source identity and access management solution, has a cross-site scripting (XSS) vulnerability in the…
Browse all CWE-79 (Cross-site Scripting (XSS)) vulnerabilities →